Funder
Philips
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Medtronic
National Institute on Aging
Boston Scientific Corporation
American Heart Association
LivaNova
Pfizer
Biotronik
Subject
Cardiology and Cardiovascular Medicine
Reference6 articles.
1. Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction;Solomon;N Engl J Med,2019
2. Atrial fibrillation in heart failure with preserved ejection fraction: the PARAGON-HF trial;Cikes;J Am Coll Cardiol HF,2022
3. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis;Healey;J Am Coll Cardiol,2005
4. Rhythm control versus rate control in patients with atrial fibrillation and heart failure with preserved ejection fraction: insights from get with the guidelines–heart failure;Kelly;J Am Heart Assoc,2019
5. Early rhythm control therapy in patients with atrial fibrillation and heart failure;Rillig;Circulation,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献